Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 108
Number of items: 108
  • Belderbos, J., Schagen, S., Walraven, I., Deprez, S., de Ruiter, M., De Ruysscher, D., & Le Pechoux , C. (2017). In Regard to Redmond et al. International Journal of Radiation Oncology Biology Physics, 99(1), 238-239. https://doi.org/10.1016/j.ijrobp.2017.05.012
  • Duijts, S. F. A., van der Beek , A. J., Boelhouwer, I. G., & Schagen, S. B. (2017). Cancer-related cognitive impairment and patients' ability to work: a current perspective. Current Opinion in Supportive and Palliative Care, 11(1), 19-23. https://doi.org/10.1097/SPC.0000000000000248
  • Russell, N. S., van Werkhoven, E., & Schagen, S. B. (2017). Quantification of patient-reported outcome measures of radiation-induced skin reactions for use in clinical trial design. Supportive Care in Cancer, 25(1), 67-74. https://doi.org/10.1007/s00520-016-3376-y
  • Menning, S., de Ruiter, M., Veltman, D. J., Boogerd, W., Oldenburg, H. S., Reneman, L., & Schagen, S. B. (2017). Demographics, PROs and fMRI task data [Data set]. Figshare. https://doi.org/10.6084/m9.figshare.4670545.v1
  • Open Access
    Jacobs, W., Das, E., & Schagen, S. B. (2017). Increased cognitive problem reporting after information about chemotherapy-induced cognitive decline: The moderating role of stigma consciousness. Psychology & Health, 32(1), 78-93. https://doi.org/10.1080/08870446.2016.1244535
  • Open Access
    Feenstra, H. E. M., Vermeulen, I. E., Murre, J. M. J., & Schagen, S. B. (2017). Online cognition: Factors facilitating reliable online neuropsychological test results. The Clinical Neuropsychologist, 31(1), 59-84. https://doi.org/10.1080/13854046.2016.1190405
  • Open Access
    Menning, S., de Ruiter, M. B., Veltman, D. J., Boogerd, W., Oldenburg, H. S. A., Reneman, L., & Schagen, S. B. (2017). Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type. PLoS ONE, 12(3), Article e0171724. https://doi.org/10.1371/journal.pone.0171724
  • Menning, S., de Ruiter, M. B., Kieffer, J. M., Agelink van Rentergem, J., Veltman, D. J., Fruijtier, A., Oldenburg, H. S. A., Boven, E., van der Meij, S., Lustig, V., Bos, M. E. M., Boogerd, W., Reneman, L., & Schagen, S. B. (2016). Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy: Results From a Longitudinal Study. Journal of Pain and Symptom Management, 52(4), 560-569. https://doi.org/10.1016/j.jpainsymman.2016.04.012
  • Schilder, C. M., Seynaeve, C., Beex, L. V., Boogerd, W., Linn, S. C., Gundy, C. M., Huizenga, H. M., Nortier, J. W., van der Velde, C. J., van Dam, F. S., & Schagen, S. B. (2010). Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with early breast cancer: results from the neuropsychological side study of the Tamoxifen and Exemestane adjuvant multinational trial. Journal of Clinical Oncology, 28(8), 1294-1300. https://doi.org/10.1200/JCO.2008.21.3553
  • Open Access
    Schilder, C. M. T. (2010). Effects of tamoxifen and exemestane on cognitive functioning: a study in postmenopausal breast cancer patients. [Thesis, fully internal, Universiteit van Amsterdam].
Page 10 of 11